These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 28692249)
1. The Emergence of Phenolic Glycans as Virulence Factors in Mycobacterium tuberculosis. Barnes DD; Lundahl MLE; Lavelle EC; Scanlan EM ACS Chem Biol; 2017 Aug; 12(8):1969-1979. PubMed ID: 28692249 [TBL] [Abstract][Full Text] [Related]
2. Role of glycans and glycoproteins in disease development by Mycobacterium tuberculosis. Sonawane A; Mohanty S; Jagannathan L; Bekolay A; Banerjee S Crit Rev Microbiol; 2012 Aug; 38(3):250-66. PubMed ID: 22324751 [TBL] [Abstract][Full Text] [Related]
3. The Cell Wall Lipid PDIM Contributes to Phagosomal Escape and Host Cell Exit of Quigley J; Hughitt VK; Velikovsky CA; Mariuzza RA; El-Sayed NM; Briken V mBio; 2017 Mar; 8(2):. PubMed ID: 28270579 [TBL] [Abstract][Full Text] [Related]
4. The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages. Stokes RW; Norris-Jones R; Brooks DE; Beveridge TJ; Doxsee D; Thorson LM Infect Immun; 2004 Oct; 72(10):5676-86. PubMed ID: 15385466 [TBL] [Abstract][Full Text] [Related]
5. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations. Källenius G; Correia-Neves M; Buteme H; Hamasur B; Svenson SB Tuberculosis (Edinb); 2016 Jan; 96():120-30. PubMed ID: 26586646 [TBL] [Abstract][Full Text] [Related]
6. Twenty Years of Mycobacterial Glycans: Furanosides and Beyond. Lowary TL Acc Chem Res; 2016 Jul; 49(7):1379-88. PubMed ID: 27294709 [TBL] [Abstract][Full Text] [Related]
7. Chemical Synthesis of Cell Wall Constituents of Holzheimer M; Buter J; Minnaard AJ Chem Rev; 2021 Aug; 121(15):9554-9643. PubMed ID: 34190544 [TBL] [Abstract][Full Text] [Related]
9. Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development. Bailo R; Bhatt A; Aínsa JA Biochem Pharmacol; 2015 Aug; 96(3):159-67. PubMed ID: 25986884 [TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis virulence: insights and impact on vaccine development. Delogu G; Provvedi R; Sali M; Manganelli R Future Microbiol; 2015; 10(7):1177-94. PubMed ID: 26119086 [TBL] [Abstract][Full Text] [Related]
11. Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. Mishra AK; Driessen NN; Appelmelk BJ; Besra GS FEMS Microbiol Rev; 2011 Nov; 35(6):1126-57. PubMed ID: 21521247 [TBL] [Abstract][Full Text] [Related]
12. Rv0180c contributes to Mycobacterium tuberculosis cell shape and to infectivity in mice and macrophages. Payros D; Alonso H; Malaga W; Volle A; Mazères S; Déjean S; Valière S; Moreau F; Balor S; Stella A; Combes-Soia L; Burlet-Schiltz O; Bouchez O; Nigou J; Astarie-Dequeker C; Guilhot C PLoS Pathog; 2021 Nov; 17(11):e1010020. PubMed ID: 34724002 [TBL] [Abstract][Full Text] [Related]
13. Biochemical and Structural Characterization of TesA, a Major Thioesterase Required for Outer-Envelope Lipid Biosynthesis in Mycobacterium tuberculosis. Nguyen PC; Nguyen VS; Martin BP; Fourquet P; Camoin L; Spilling CD; Cavalier JF; Cambillau C; Canaan S J Mol Biol; 2018 Dec; 430(24):5120-5136. PubMed ID: 30292819 [TBL] [Abstract][Full Text] [Related]
14. Cell envelope lipids in the pathophysiology of Mycobacterium tuberculosis. Singh P; Rameshwaram NR; Ghosh S; Mukhopadhyay S Future Microbiol; 2018 May; 13():689-710. PubMed ID: 29771143 [TBL] [Abstract][Full Text] [Related]